Iop Instituto de Oncologia Do Parana

Curitiba, Paraná 80530-010

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cholangiocarcinoma, Breast Cancer, FGFR2 Gene Rearrangements, Triple-negative Breast Cancer

Studies at this site

• A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) — Completed
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early
• A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer — Completed